US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Acquired haemophilia (AH) is a rare disorder caused by autoantibodies against factor VIII.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Haemophilia

Title: Haemophilia : the official journal of the World Federation of Hemophilia

Publisher: Wiley

ISSN (Electronic): 1365-2516

ISSN (Print): 1351-8216

Publication date (Electronic): Jan 2016

Volume: 22

Issue: 1

Affiliations

[1 ] Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

[2 ] Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

[3 ] Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State College of Medicine, Hershey, PA, USA.

[4 ] Clinical, Medical, and Regulatory Affairs, Novo Nordisk Inc., Plainsboro, NJ, USA.

Article

DOI: 10.1111/hae.12852

PubMed ID: 26551409

SO-VID: 15413c9c-2a9b-423c-82f6-c74371d7f2f3

History

Keywords: haemostasis,rFVIIa,registry,safety,surgery,acquired haemophilia

Data availability:

Keywords: haemostasis, rFVIIa, registry, safety, surgery, acquired haemophilia

Comments

Comment on this article

Cited by 12

See all cited by